Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling

Journal of Psychopharmacology

Volumn 28, Issue 6, 2014, Pages 545-552

  Buchborn, Tobias ^a   Schröder, Helmut ^a   Höllt, Volker ^a   Grecksch, Gisela ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

animal model; antidepressant; avoidance learning; hippocampus; lysergic acid diethylamide; olfactory bulbectomy; Serotonergic hallucinogen; serotonin 5 HT2A receptor

Indexed keywords

DOPAMINE; IMIPRAMINE; LYSERGIDE; NORADRENALIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 2A RECEPTOR; ANTIDEPRESSANT AGENT; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR CHANGE; BINDING AFFINITY; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; HIPPOCAMPUS; LEARNING; MALE; NEUROCHEMISTRY; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; ANIMAL; DISEASE MODEL; DRUG ADMINISTRATION; DRUG EFFECTS; METABOLISM; OLFACTORY BULB; PATHOPHYSIOLOGY; PSYCHOLOGY; SURGERY; SYNAPTIC TRANSMISSION; TIME FACTOR; WISTAR RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; HIPPOCAMPUS; LYSERGIC ACID DIETHYLAMIDE; MALE; OLFACTORY BULB; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 84901595847     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881114531666     Document Type: Article

References (77)

1. Araneda R, Andrade R. 5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience. 1991 ; 40: 399-412
2. Banasr M, Hery M, Printemps R, et al. Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone. Neuropsychopharmacology. 2004 ; 29: 450-460
3. Bedard P, Pycock C J. 'Wet-Dog' shake behaviour in the rat: A possible quantitative model of central 5-hydroxytryptamine activity. Neuropharmacology. 1977 ; 16: 663-670
4. Bignami G. Facilitation of avoidance acquisition by LSD-25. Psychopharmacologia. 1972 ; 25: 146-151
5. Bonson KR, Buckholtz JW, Murphy DL. Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans. Neuropsychopharmacology. 1996 ; 14: 425-436
6. Broekkamp CL, Garrigou D, Lloyd KG. Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomised rats. Pharmacol Biochem Behav. 1980 ; 13: 643-646
7. Buckholtz NS, Freedman DX, Middaugh LD. Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain. Eur J Pharmacol. 1985 ; 109: 421-425
8. Buckholtz NS, Zhou DF, Freedman DX. Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors. Life Sci. 1988 ; 42: 2439-2445
9. Buckholtz NS, Zhou DF, Freedman DX, et al. Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain. Neuropsychopharmacology. 1990 ; 3: 137-148
10. Cairncross KD, Cox B, Forster C, et al. Olfactory projection systems, drugs and behaviour: A review. Psychoneuroendocrinology. 1979 ; 4: 253-272
11. Cairncross KD, Schofield S, King HG. The implication of noradrenaline in avoidance learning in the rat. Prog Brain Res. 1973 ; 39: 481-485
12. Carhart-Harris RL, Leech R, Williams TM, et al. Implications for psychedelic-assisted psychotherapy: Functional magnetic resonance imaging study with psilocybin. Br J Psychiatry. 2012 ; 200: 238-244
13. Castellano C. Effects of LSD-25 on avoidance behavior and locomotor activity in mice. Psychopharmacology. 1979 ; 62: 145-149
14. Cohen S. Lysergic acid diethylamide: Side effects and complications. J Nerv Ment Dis. 1960 ; 130: 30-40
15. Croll SD, Suri C, Compton DL, et al. Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience. 1999 ; 93: 1491-1506
16. Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: Recent developments and future needs. Trends Pharmacol Sci. 2002 ; 23: 238-245
17. De Lima Osório F, de Macedo LRH, de Sousa JPM, et al The Ethnopharmacology of Ayahuasca. Dos Santos RG, ed. Kerala: Transworld Research Network ; 2011: 75-85.
18. Doat-Meyerhoefer MM, Hard R, Winter JC, et al. Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas. Pharmacol Biochem Behav. 2005 ; 81: 750-757
19. Domino E, Caldwell D, Henke R. Effects of psychoactive agents on acquisition of conditioned pole jumping in rats. Psychopharmacologia. 1965 ; 8: 285-289
20. Earley B, Glennon M, Lally M, et al. Autoradiographic distribution of cholinergic muscarinic receptors and serotonin2 receptors in olfactory bulbectomized (OB) rats after chronic treatment with mianserin and desipramine. Hum Psychopharmacol. 1994 ; 9: 397-407
21. Frieder B, Allweis C. Memory consolidation: Further evidence for the four-phase model from the time-courses of diethyldithiocarbamate and ethacrinic acid amnesias. Physiol Behav. 1982 ; 29: 1071-1075
22. Garrigou D, Broekkamp CL, Lloyd KG. Involvement of the amygdala in the effect of antidepressants on the passive avoidance deficit in bulbectomised rats. Psychopharmacology. 1981 ; 74: 66-70
23. Gebhardt N, Bär K-J, Boettger MK, et al. Vagus nerve stimulation ameliorated deficits in one-way active avoidance learning and stimulated hippocampal neurogenesis in bulbectomized rats. Brain Stimulat. 2013 ; 6: 78-83
24. Goodwin GM, Green AR, Johnson P. 5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice. Br J Pharmacol. 1984 ; 83: 235-242
25. Gorka Z, Wojtasik E, Kwiatek H, et al. Action of serotoninmimetics in the behavioral despair test in rats. Commun Psychopharmacol. 1979 ; 3: 133-136
26. Gray JA, Roth BL. Paradoxical trafficking and regulation of 5-HT2A receptors by agonists and antagonists. Brain Res Bull. 2001 ; 56: 441-451
27. Grecksch G, Zhou D, Franke C, et al. Influence of olfactory bulbectomy and subsequent imipramine treatment on 5-hydroxytryptaminergic presynapses in the rat frontal cortex: Behavioural correlates. Br J Pharmacol. 1997 ; 122: 1725-1731
28. Gresch PJ, Smith RL, Barrett RJ, et al. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex. Neuropsychopharmacology. 2005 ; 30: 1693-1702
29. Grob CS, Danforth AL, Chopra GS, et al. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry. 2011 ; 68: 71-78
30. Gurevich EV, Aleksandrova IA, Otmakhova NA, et al. Effects of bulbectomy and subsequent antidepressant treatment on brain 5-HT2 and 5-HT1A receptors in mice. Pharmacol Biochem Behav. 1993 ; 45: 65-70
31. Haddjeri N, Blier P, de Montigny C. Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J Neurosci. 1998 ; 18: 10150-10156
32. Harmer CJ. Serotonin and emotional processing: Does it help explain antidepressant drug action?. Neuropharmacology. 2008 ; 55: 1023-1028
33. Harmer CJ, Goodwin GM, Cowen PJ. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry. 2009 ; 195: 102-108
34. Hellweg R, Zueger M, Fink K, et al. Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas. Neurobiol Dis. 2007 ; 25: 1-7
35. Hintzen A, Passie T The Pharmacology of LSD: A Critical Review. New York: Oxford University Press ; 2010 :
36. Ismaiel AM, Titeler M, Miller KJ, et al. 5-HT1 and 5-HT2 binding profiles of the serotonergic agents.alpha.-methylserotonin and 2-methylserotonin. J Med Chem. 1990 ; 33: 755-758
37. Jaako-Movits K, Zharkovsky A. Impaired fear memory and decreased hippocampal neurogenesis following olfactory bulbectomy in rats. Eur J Neurosci. 2005 ; 22: 2871-2878
38. Jesberger JA, Richardson JS. Animal models of depression: Parallels and correlates to severe depression in humans. Biol Psychiatry. 1985 ; 20: 764-784
39. Kang S, Green JP. Steric and electronic relationships among some hallucinogenic compounds. Proc Natl Acad Sci U S A. 1970 ; 67: 62-67
40. Katz MM, Waskow IE, Olsson J. Characterizing the psychological state produced by LSD. J Abnorm Psychol. 1968 ; 73: 1-14
41. Kelly JP, Wrynn AS, Leonard BE. The olfactory bulbectomized rat as a model of depression: An update. Pharmacol Ther. 1997 ; 74: 299-316
42. Kurland AA, Grof S, Pahnke WN, et al Psychopharmacological Agents for the Terminally Ill and Bereaved. Goldberg IK Malitz S Kutscher AH, ed. New York:: Columbia University Press ; 1973: 86-133.
43. Lucki I, Frazer A. Prevention of the serotonin syndrome in rats by repeated administration of monoamine oxidase inhibitors but not tricyclic antidepressants. Psychopharmacology. 1982 ; 77: 205-211
44. Marks HE, Remley NR, Seago JD, et al. Effects of bilateral lesions of the olfactory bulbs of rats on measures of learning and motivation. Physiol Behav. 1971 ; 7: 1-6
45. Marona-Lewicka D, Chemel BR, Nichols DE. Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI. Psychopharmacology (Berl). 2009 ; 203: 265-277
46. Mascher E Neuro-psycho-pharmacology. Proceedings of the 5th international congress. Brill H Cole JO, ed. Amsterdam: Excerpta Medica ; 1967: 441-444.
47. Masini CV, Holmes PV, Freeman KG, et al. Dopamine overflow is increased in olfactory bulbectomized rats: An in vivo microdialysis study. Physiol Behav. 2004 ; 81: 111-119
48. Mathews A, MacLeod C. Cognitive vulnerability to emotional disorders. Annu Rev Clin Psychol. 2004 ; 1: 167-195
49. Metzner R, Litwin G, Weil GM. The relation of expectation and mood to psilocybin reactions: A questionnaire study. Psychedelic Rev. 1963 ; 1: 18-26
50. Mittman S, Geyer M. Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol. Psychopharmacology. 1991 ; 105: 69-76
51. Montagne M Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments. Winkelman M Roberts TB, ed. Westport: Praeger ; 2007: 177-190.
52. Nesterova IV, Gurevich EV, Nesterov VI, et al. Bulbectomy-induced loss of raphe neurons is counteracted by antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry. 1997 ; 21: 127-140
53. Ogren SO. Serotonin receptor involvement in the avoidance learning deficit caused by pchloroamphetamine-induced serotonin release. Acta Physiol Scand. 1986 ; 126: 449-462
54. Osei-Owusu P, James A, Crane J, et al. 5-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome. J Pharmacol Exp Ther. 2005 ; 313: 1324-1330
55. Otmakhova NA, Gurevich EV, Katkov YA, et al. Dissociation of multiple behavioral effects between olfactory bulbectomized C57B1/6J and DBA/2J mice. Physiol Behav. 1992 ; 52: 441-448
56. Passie T Psycholytic and Psychedelic Therapy Research 1931-1995: A Complete International Bibliography. Hannover: Laurentius. ; 1997 :
57. Ray TS. Psychedelics and the human receptorome. PLoS ONE. 2010 ; 5: e9019
58. Riedlinger TJ, Riedlinger JE. Psychedelic and entactogenic drugs in the treatment of depression. J Alt States Conscious. 1994 ; 26: 41-55
59. Romano A, Quinn J, Li L, et al. Intrahippocampal LSD accelerates learning and desensitizes the 5-HT2A receptor in the rabbit. Psychopharmacology. 2010 ; 212: 441-448
60. Roth BL, Baner K, Westkaemper R, et al. Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist. Proc Natl Acad Sci U S A. 2002 ; 99: 11934-11939
61. Sairanen M, Lucas G, Ernfors P, et al. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci. 2005 ; 25: 1089-1094
62. Santarelli L, Saxe M, Gross C, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science. 2003 ; 301: 805-809
63. Savage C, Mc Cabe OL, Kurland AA, et al. LSD-assisted psychotherapy in the treatment of severe chronic neuroses. J Alt States Conscious. 1973 ; 1: 31-47
64. Savitz J, Lucki I, Drevets WC. 5-HT1A receptor function in major depressive disorder. Prog Neurobiol. 2009 ; 88: 17-31
65. Schmidt J. Die Beeinflussung einer bedingten motorischen Fluchtreaktion der Ratte durch Noradrenalin, Serotonin und Lysergsäurediäthylamid. Acta Biol Med Ger. 1963 ; 10: 343-349
66. Song C, Leonard BE. The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev. 2005 ; 29: 627-647
67. Strassman RJ. Adverse reactions to psychedelic drugs. A review of the literature. J Nerv Ment Dis. 1984 ; 172: 577-595
68. Surget A, Tanti A, Leonardo ED, et al. Antidepressants recruit new neurons to improve stress response regulation. Mol Psychiatry. 2011 ; 16: 1177-1188
69. Szabo ST, Blier P. Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus. Neuropsychopharmacology. 2001 ; 25: 845-857
70. Taeschler M, Weidmann H, Cerletti A. The effect of LSD on reaction times in a conditioned avoidance reaction and in the analgesia test. Helv Physiol Pharmacol Acta. 1960 ; 18: 43-49
71. Thomas JB. Some behavioral effects of olfactory bulb damage in the rat. J Comp Physiol Psychol. 1973 ; 83: 140-148
72. Unger SM. LSD and psychotherapy: A bibliography of the English-language literature. Psych Rev. 1964 ; 1: 442-449
73. Vaidya VA, Terwilliger RMZ, Duman RS. Role of 5-HT2A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci Lett. 1999 ; 262: 1-4
74. Van der Stelt HM, Breuer ME, Olivier B, et al. Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: An in vivo microdialysis study. Biol Psychiatry. 2005 ; 57: 1061-1067
75. Vollenweider FX, Kometer M. The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders. Nat Rev Neurosci. 2010 ; 11: 642-651
76. Winkelman MJ, Roberts TB Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments. Westport: Praeger ; 2007 :
77. Zhang Y, Damjanoska KJ, Carrasco GA, et al. Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI. J Neurosci. 2002 ; 22: 9635-9642